DEE-INX 60 is a proton pump inhibitor used in acid-related gastrointestinal disorders. It provides prolonged acid suppression and symptom relief. The formulation is effective in GERD, esophagitis, and gastric ulcers. DEE-INX 60 improves healing of the gastric mucosa. Well suited for long-term acid control.
Dee-Inx 60 contains Dexlansoprazole, a next-generation proton pump inhibitor (PPI) designed to provide prolonged and consistent acid suppression, helping patients achieve sustained relief from acid-related disorders.
Clinical advantages designed for effective acid control and patient comfort
Provides effective relief in non-erosive gastro-esophageal reflux disease (GERD)
Dual delayed-release mechanism ensures extended acid control throughout the day and night
Helps reduce heartburn, epigastric pain, regurgitation, and acid reflux symptoms
Faster and improved bioavailability compared to conventional PPIs
Long half-life (approx. 18 hours) supports once-daily dosing
Well tolerated with minimal side effects
Dexlansoprazole suppresses gastric acid secretion by inhibiting the H⁺/K⁺-ATPase enzyme system at the gastric parietal cell level, offering reliable and long-lasting acid control.
Dee-Inx 60 is indicated for management of acid-related and gastrointestinal disorders.